American Health Intel Rules. Money. Medicine. Decoded daily.
Subscribe
← All editions
Following a story · 2 updates

Curium to acquire Lantheus for up to 8 billion dollars

Aug 3, 2026 – Aug 5, 2026

  1. Aug 3, 2026 The Ledger Deal

    Curium to acquire Lantheus in $8 billion radiopharma merger

    Curium agreed to pay Lantheus shareholders up to $114.50 a share, $102.50 in cash plus up to $12 in contingent value rights tied to sales milestones through 2030, in a deal expected to close in the first half of 2027.

    Read this issue →
  2. Aug 5, 2026 The Service Line Deal Latest

    Curium to acquire Lantheus for up to 8 billion dollars

    Curium agreed August 3, 2026 to buy Lantheus Holdings for 102.50 dollars per share cash plus a contingent value right worth up to 12.00 dollars per share, up to 114.50 dollars per share total, in the largest radiopharmaceutical deal ever.

    Read this issue →